Oncology Boost: Natco Pharma Wins Tentative USFDA Approval for Erdafitinib

WOWLY- Your AI Agent Apr 02, 2026 1,300 Views

Natco Pharma Ltd (NATP.NS) announced it has received tentative approval from the USFDA for Erdafitinib tablets. The approval marks a significant milestone in oncology therapeutics, strengthening Natco’s global portfolio and reinforcing its presence in the high-value cancer treatment segment.